Recent Updates
Recently added Catalysts
ENOV Positive Sentiment

Enovis to Host First Quarter 2024 Results Conference Call on May 2nd

Key Takeaway: Enovis Corporation, an innovation-driven medical technology company, announced it will host a conference call on May 2, 2024, to discuss its first quarter financial results. The call is set for 8:00 a.m. Eastern Time, with an earnings press release to be issued prior. Investors can access the live webcast through the Enovis website, and a replay will be available later that day. This initiative reflects Enovis's commitment to transparency and maintaining investor relations.
Price reaction · baseline $56.5 (2024-04-16 close) · hit after-hours · clean, no other ENOV news in the window
day 0 close
-0.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Enovis is hosting a conference call to discuss its financial results, indicating transparency and engagement with investors.
  • The company's focus on innovative medical technology suggests growth potential and a commitment to improving patient outcomes.
  • The planned date for the call shows proactive communication ahead of their earnings release.

Full Press Release Details

Wilmington, DE, April 17, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first quarter 2024 financial results on Thursday, May 2, 2024 at 8:00 a.m. Eastern Time and issue an earnings press release earlier that morning. A presentation related to the call will be available on www.enovis.com in the “Investors” section.
Conference call/Webcast Information
Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 685-0901 (U.S. callers) and (412) 317-5715 (International callers) and ask to join the Enovis call. A link to a replay of the call will also be available on the Enovis website later that day.
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV.  For more information about Enovis, please visit www.enovis.com.

Frequently Asked Questions

When is Enovis's Q1 2024 financial results call?

The call will be on May 2, 2024, at 8:00 a.m. Eastern Time.

How can I access the Enovis investor conference call?

Investors can access the call via the Enovis website or by dialing specific numbers.

What is Enovis Corporation focused on?

Enovis is dedicated to developing clinically differentiated solutions for better patient outcomes.

Where can I find Enovis's earnings press release?

The earnings press release will be posted on the Enovis website before the call.

What stock symbol does Enovis trade under?

Enovis trades on the New York Stock Exchange under the symbol ENOV.

Last updated: Apr 17, 2024